Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
Effect of PA-824 and PA-824 plus Moxifloxacin on the QTc Interval in Health Volunteers
Study Director
Start Date
9 / 2012
Trial Phase
Trial Status
in data analysis
Current Enrollment
74
Target Enrollment
75
Overview